Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Tuberculosis

Volumn 94, Issue 3, 2014, Pages 226-237

  Poyntz, Hazel C ^a   Stylianou, Elena ^a   Griffiths, Kristin L ^a,b   Marsay, Leanne ^a   Checkley, Anna M ^a,c   McShane, Helen ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Bacillus Calmette Geurin; Mouse model; Mycobacterium avium; Non tuberculous mycobacteria; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA; AEROSOL; CYTOKINE; IMMUNOLOGICAL ADJUVANT; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATYPICAL MYCOBACTERIUM; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; MOUSE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TUBERCULOSIS; AEROSOL; ANIMAL; C57BL MOUSE; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LUNG TUBERCULOSIS; LYMPH NODE; METABOLISM; MYCOBACTERIUM AVIUM COMPLEX; ORAL DRUG ADMINISTRATION; SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; AEROSOLS; ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; IMMUNITY, CELLULAR; LYMPH NODES; MICE, INBRED C57BL; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TH1 CELLS; TUBERCULOSIS, PULMONARY; VACCINES, ATTENUATED; VACCINES, LIVE, UNATTENUATED;

EID: 84900825294     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.12.006     Document Type: Article

References (55)

1. Organisation WH Global tuberculosis report 2012 2012 WHO Library Cataloguing in Publication Data
2. G. Walzl, K. Ronacher, W. Hanekom, T.J. Scriba, and A. Zumla Immunological biomarkers of tuberculosis Nat Rev Immunol 11 2011 343 354
3. I. Kramnik, D. Radzioch, and E. Skamene T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guerin-infected resistant and susceptible mice Immunology 81 1994 618 625
4. D. Begum, M. Umemura, A. Yahagi, Y. Okamoto, S. Hamada, K. Oshiro, and G. Matsuzaki Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guerin Immunology 128 2009 556 563
5. J.C. Hope, L.S. Kwong, P. Sopp, R.A. Collins, and C.J. Howard Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guerin vaccinated and nonvaccinated cattle Scand J Immunol 52 2000 285 291
6. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg, and F. Mosteller Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature J Am Med Assoc 271 1994 698 702
7. L.C. Rodrigues, V.K. Diwan, and J.G. Wheeler Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis Int J Epidemiol 22 1993 1154 1158
8. M.R. Lagranderie, A.M. Balazuc, E. Deriaud, C.D. Leclerc, and M. Gheorghiu Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains Infect Immun 64 1996 1 9
9. M.A. Horwitz, G. Harth, B.J. Dillon, and S. Maslesa-Galic Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis Vaccine 27 2009 441 445
10. P.D. Hart, and I. Sutherland BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life Br Med J 2 1977 293 295
11. G.V. Baily Tuberculosis prevention trial, Madras Indian J Med Res 72 Suppl. 1980 1 74
12. F. Abebe, and G. Bjune The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link? Clin Exp Immunol 145 2006 389 397
13. B. Lopez, D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L. Barrera, K. Kremer, R. Hernandez-Pando, K. Huygen, and D. van Soolingen A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes Clin Exp Immunol 133 2003 30 37
14. I. Malhotra, P. Mungai, A. Wamachi, J. Kioko, J.H. Ouma, J.W. Kazura, and C.L. King Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis J Immunol 162 1999 6843 6848
15. D. Elias, H. Akuffo, A. Pawlowski, M. Haile, T. Schon, and S. Britton Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis Vaccine 23 2005 1326 1334
16. D. Elias, S. Britton, A. Aseffa, H. Engers, and H. Akuffo Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production Vaccine 26 2008 3897 3902
17. J.L. Stanford, M.J. Shield, and G.A. Rook How environmental mycobacteria may predetermine the protective efficacy of BCG Tubercle 62 1981 55 62
18. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
19. WHO Weekly epidemiological record vol. 4 2004
20. M.A. De Groote, N.R. Pace, K. Fulton, and J.O. Falkinham III Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils Appl Environ Microbiol 72 2006 7602 7606
21. S.M. September, V.S. Brozel, and S.N. Venter Diversity of nontuberculoid Mycobacterium species in biofilms of urban and semiurban drinking water distribution systems Appl Environ Microbiol 70 2004 7571 7573
22. R.E. Weir, G.F. Black, B. Nazareth, S. Floyd, S. Stenson, C. Stanley, K. Branson, L. Sichali, S.D. Chaguluka, L. Donovan, A.C. Crampin, P.E. Fine, and H.M. Dockrell The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi Clin Exp Immunol 146 2006 390 399
23. Trial of BCG vaccines in south India for tuberculosis prevention: first report-Tuberculosis Prevention Trial Bull World Health Organ 57 1979 819 827
24. G.W. de Lisle, B.J. Wards, B.M. Buddle, and D.M. Collins The efficacy of live tuberculosis vaccines after presentization with Mycobacterium avium Tuberc (Edinb) 85 2005 73 79
25. I.M. Orme, and F.M. Collins Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria Infect Immun 44 1984 28 32
26. F.M. Collins Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species Infect Immun 4 1971 688 696
27. L. Brandt, J. Feino Cunha, A. Weinreich Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis Infect Immun 70 2002 672 678
28. R. Hernandez-Pando, L. Pavon, K. Arriaga, H. Orozco, V. Madrid-Marina, and G. Rook Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection Infect Immun 65 1997 3317 3327
29. C.J. Howard, L.S. Kwong, B. Villarreal-Ramos, P. Sopp, and J.C. Hope Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG Clin Exp Immunol 130 2002 190 195
30. E. Lozes, O. Denis, A. Drowart, F. Jurion, K. Palfliet, A. Vanonckelen, J. De Bruyn, M. De Cock, J.P. Van Vooren, and K. Huygen Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group Scand J Immunol 46 1997 16 26
31. S.L. Young, L. Slobbe, R. Wilson, B.M. Buddle, G.W. de Lisle, and G.S. Buchan Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination Infect Immun 75 2007 2833 2840
32. L.E. Bermudez Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma J Immunol 150 1993 1838 1845
33. P. Ho, X. Wei, and G.T. Seah Regulatory T cells induced by Mycobacterium chelonae sensitization influence murine responses to bacille Calmette-Guerin J Leukoc Biol 88 2010 1073 1080
34. B.M. Buddle, B.J. Wards, F.E. Aldwell, D.M. Collins, and G.W. de Lisle Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis Vaccine 20 2002 1126 1133
35. C. Demangel, T. Garnier, I. Rosenkrands, and S.T. Cole Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens Infect Immun 73 2005 2190 2196
36. I.M. Orme, A.R. Roberts, and F.M. Collins Lack of evidence for a reduction in the efficacy of subcutaneous BCG vaccination in mice infected with nontuberculous mycobacteria Tubercle 67 1986 41 46
37. M. Thom, C. Howard, B. Villarreal-Ramos, E. Mead, M. Vordermeier, and J. Hope Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection Tuberc (Edinb) 88 2008 324 334
38. M.L. Edwards, J.M. Goodrich, D. Muller, A. Pollack, J.E. Ziegler, and D.W. Smith Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guerin J Infect Dis 145 1982 733 741
39. D.K. Flaherty, B. Vesosky, G.L. Beamer, P. Stromberg, and J. Turner Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination J Leukoc Biol 80 2006 1262 1271
40. J.B. Torrelles, D. Ellis, T. Osborne, A. Hoefer, I.M. Orme, D. Chatterjee, P.J. Brennan, and A.M. Cooper Characterization of virulence, colony morphotype and the glycopeptidolipid of Mycobacterium avium strain 104 Tuberc (Edinb) 82 2002 293 300
41. E.K. Forbes, C. Sander, E.O. Ronan, H. McShane, A.V. Hill, P.C. Beverley, and E.Z. Tchilian Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice J Immunol 181 2008 4955 4964
42. S.A. Khader, G.K. Bell, J.E. Pearl, J.J. Fountain, J. Rangel-Moreno, G.E. Cilley, F. Shen, S.M. Eaton, S.L. Gaffen, S.L. Swain, R.M. Locksley, L. Haynes, T.D. Randell, and A.M. Cooper IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge Nat Immunol 8 2007 369 377
43. H.W. Mittrucker, U. Steinhoff, A. Kohler, M. Krause, D. Lazar, P. Mex, D. Miekley, and S.H. Kaufmann Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis Proc Natl Acad Sci U S A 104 2007 12434 12439
44. A. Izcue, J.L. Coombes, and F. Powrie Regulatory lymphocytes and intestinal inflammation Annu Rev Immunol 27 2009 313 338
45. C.C. Bain, and A.M. Mowat Intestinal macrophages - specialised adaptation to a unique environment Eur J Immunol 41 2011 2494 2498
46. M. Petrofsky, and L.E. Bermudez CD4+ T cells but not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route Infect Immun 73 2005 2621 2627
47. L.E. Bermudez, and J. Champsi Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice Infect Immun 61 1993 3093 3097
48. N. Hsu, L.S. Young, and L.E. Bermudez Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex Infect Immun 63 1995 528 533
49. A. Gupta, A. Kaul, A.G. Tsolaki, U. Kishore, and S. Bhakta Mycobacterium tuberculosis: immune evasion, latency and reactivation Immunobiology 217 2012 363 374
50. Y.J. Jung, R. LaCourse, L. Ryan, and R.J. North Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice Infect Immun 70 2002 6436 6443
51. R. Hernandez-Pando, H. Orozcoe, A. Sampieri, L. Pavon, C. Velasquillo, J. Larriva-Sahd, J.M. Alcocer, and M.V. Madrid Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis Immunology 89 1996 26 33
52. I.M. Orme, A.D. Roberts, J.P. Griffin, and J.S. Abrams Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection J Immunol 151 1993 518 525
53. F.J. Sangari, J. Goodman, M. Petrofsky, P. Kolonoski, and L.E. Bermudez Mycobacterium avium invades the intestinal mucosa primarily by interacting with enterocytes Infect Immun 69 2001 1515 1520
54. R.E. Weir, G.F. Black, H.M. Dockrell, S. Floyd, P.E. Fine, S.D. Chaguluka, S. Stenson, E. King, B. Nazareth, D.K. Warndorff, B. Ngwira, A.C. Crampin, L. Mwaungulu, L. Sichali, E. Jarman, L. Donovan, and J.M. Blackwell Mycobacterial purified protein derivatives stimulate innate immunity: malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom Infect Immun 72 2004 1807 1811
55. J. Kleinnijenhuis, M. Oosting, L.A. Joosten, M.G. Netea, and R. Van Crevel Innate immune recognition of Mycobacterium tuberculosis Clin Dev Immunol 2011 2011 405310